Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Compass Therapeutics, Inc. - Common Stock (NQ:CMPX)

3.740 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Compass Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >
Compass Therapeutics Inc (NASDAQ:CMPX) Reports Wider Q2 2025 Loss, Shares Show Mixed Reaction Amid Clinical Progress
Compass Therapeutics reports Q2 2025 results with a wider-than-expected loss but shows progress in clinical trials for oncology treatments. Market reacts mixedly. 
Via Chartmill
Compass Therapeutics Posts Wider Q2 Loss
Via The Motley Fool
Topics Intellectual Property
Top movers in Wednesday's session
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements. 
Via Chartmill
Small Cap Compass Therapeutics Shares Positive Primary Goal Data From Pivotal Cancer Drug Study For Biliary Tract Cancer
Compass Therapeutics' Phase 2/3 trial shows tovecimig plus paclitaxel significantly improves response rates in advanced biliary tract cancer patients. 
Via Benzinga
Recap: Compass Therapeutics Q3 Earnings
 
Via Benzinga
Compass Therapeutics: Q1 Earnings Insights
 
Via Benzinga
Earnings Scheduled For August 11, 2025
 
Via Benzinga
What's going on in today's after hours session
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
This Smithfield Foods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
 
Via Benzinga
Top 3 High-Momentum Companies Analysts Are Still Bullish On
Momentum investors seek to take advantage of share price rallies to buy companies before they peak; analysts think these three firms still have room to grow. 
Via MarketBeat
CMPX Stock Earnings: Compass Therapeutics Meets EPS for Q2 2024
CMPX stock results show that Compass Therapeutics met analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
CMPX Stock Earnings: Compass Therapeutics Beats EPS for Q1 2024
CMPX stock results show that Compass Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
3 Penny Stocks With the Power to 10X Your $1K Investment
The 10X penny stocks discussed here are a much more reliable investment than many other alternatives investors are likely to encounter. 
Via InvestorPlace
CMPX Stock Earnings: Compass Therapeutics Misses EPS for Q4 2023
CMPX stock results show that Compass Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
3 Healthcare Stocks To Make You The Millionaire Next Door: October Edition
These are the healthcare stocks to buy as they represent companies investing in research and development for growth and value creation. 
Via InvestorPlace
Why NextGen Healthcare Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) rose 65.3% to $12.20 in pre-market trading after gaining around 9% on Friday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.